HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Related Collections Related Article

Ann Thorac Surg 1997;63:1256
© 1997 The Society of Thoracic Surgeons

---

Discussion

Discussion

The first 20% of the full text of this article appears below.

See also page 1251.

DR JOSEPH B. ZWISCHENBERGER (Galveston, TX): On review of this well-written manuscript, I am pleased to see a clinically relevant study of the heralded molecule nitric oxide as a selective pulmonary vasodilator in postoperative cardiac surgical patients. I also congratulate the Program Committee for selecting a timely, yet negative study for presentation.

This clinical study does not use matched controls or prospective randomization, but it does compare clinically pertinent groups with carefully controlled secondary variables such as anesthesia technique, ventilator management, and preload. Likewise, all the raw data are included for critical review. Notably, nitric oxide produced a significant reduction in pulmonary artery pressure in patients after coronary artery bypass grafting with no change in cardiac output, left atrial . . . [Full Text of this Article]

Related Article

Variable Response to Inhaled Nitric Oxide After Cardiac Surgery

David A. Fullerton, James Jaggers, Mary M. Wollmering, Fran Piedalue, Frederick L. Grover, and Robert C. McIntyre, Jr
Ann. Thorac. Surg. 1997 63: 1251-1256. [Abstract] [Full Text]